BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15042902)

  • 1. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Brandts F
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):505; author reply 505. PubMed ID: 15042902
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's information needs about ductal carcinoma in situ before mammographic screening and after diagnosis: a qualitative study.
    Prinjha S; Evans J; McPherson A
    J Med Screen; 2006; 13(3):110-4. PubMed ID: 17007650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of 23,810 cases of ductal carcinoma-in-situ.
    Sumner WE; Koniaris LG; Snell SE; Spector S; Powell J; Avisar E; Moffat F; Livingstone AS; Franceschi D
    Ann Surg Oncol; 2007 May; 14(5):1638-43. PubMed ID: 17245612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pictorial journey through variants of ductal carcinoma in situ (DCIS) and DCIS mimickers.
    Resetkova E
    Clin Breast Cancer; 2012 Oct; 12(5):347-63. PubMed ID: 23040003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal alterations associated with the transition from in situ to invasive breast cancer.
    Ellsworth RE; Vertrees A; Love B; Hooke JA; Ellsworth DL; Shriver CD
    Ann Surg Oncol; 2008 Sep; 15(9):2519-25. PubMed ID: 18622645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atypical epithelial hyperplasias, ductal and lobular carcinoma in situ. Treatment, follow-up and prognosis].
    Käresen R; Hagen S
    Tidsskr Nor Laegeforen; 1987 Mar; 107(9):859-60, 865. PubMed ID: 3035745
    [No Abstract]   [Full Text] [Related]  

  • 10. A sacrifice for others? Ethical dilemmas surrounding the UK randomised trial for the management of screen-detected ductal carcinoma in situ of the breast.
    Thornton H
    Prof Nurse; 1993 Mar; 8(6):402-4. PubMed ID: 8383335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography.
    Welch HG; Woloshin S; Schwartz LM
    J Natl Cancer Inst; 2008 Feb; 100(4):228-9. PubMed ID: 18270336
    [No Abstract]   [Full Text] [Related]  

  • 12. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
    Rabban JT; Koerner FC; Lerwill MF
    Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ductal carcinoma in situ of the breast].
    Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; Gili S; Lo Schiavo F
    G Chir; 2006; 27(1-2):40-4. PubMed ID: 16608632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Tjalma WA
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):507; author reply 507. PubMed ID: 15042904
    [No Abstract]   [Full Text] [Related]  

  • 16. The ductal carcinoma in situ (DCIS) dilemma.
    Gur D
    Acad Radiol; 2010 Feb; 17(2):133-4. PubMed ID: 20123347
    [No Abstract]   [Full Text] [Related]  

  • 17. The dilemma of DCIS.
    Morrow M; O'Sullivan MJ
    Breast; 2007 Dec; 16 Suppl 2():S59-62. PubMed ID: 17714949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ductal carcinoma in situ of the breast (DCIS) under 40: a specific management?].
    Tunon de Lara C
    Gynecol Obstet Fertil; 2008 May; 36(5):499-506. PubMed ID: 18467151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.